Genetic landscape of congenital pouch colon: systematic review and functional enrichment study
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Nov 2024 · 1 min read
In brief
In brief
This systematic review identifies genetic variants and molecular pathways underlying congenital pouch colon, a rare anorectal malformation. Analysis of 20 cases revealed mutations in 11 genes, with Wnt and HOX pathways implicated in disease pathogenesis, providing insights for genetic counseling and personalized treatment approaches.
- CPC involves variants in 11 genes including MUC5B, FRG1, and TAF1B affecting mucosal barrier, colonic muscle development, and rRNA transcription
- Genetic hotspots identified on chromosomes 11, 16, and 17 with RGPD2/RGPD4 showing differential expression in bowel tissue
- Wnt and HOX signaling pathways implicated in CPC pathogenesis, with JAG1 and MLL genes playing key roles
- 24 missense SNPs and 63 frameshift variants identified across 20 CPC cases, establishing genetic architecture for this rare anomaly
- Findings require validation in larger, diverse cohorts and functional studies before clinical application in genetic counseling
Written by the GCMD Library team from the article.
Abstract
Background
Despite extensive clinical documentation, few studies have explored the genetic basis of congenital pouch colon (CPC) which is crucial for early detection, personalized treatment, and genetic counselling.
Objective
To compile the information on the genetic basis of CPC and the functional enrichment of underlying molecular pathways.
Materials and methods
The review was conducted in accordance with PRISMA guidelines. The implicated genes were investigated for underlying molecular pathways. A network was subsequently created on String-database followed by gene-ontology analysis.
Results
The study included 20 CPC cases and 52 controls (across 4 studies). Numerous variants, including 24 missense SNPs, 63 frameshift variants, and stop-gain/stop-loss mutations in 11 genes were identified. Notable genetic markers included MUC5B, FRG1, and TAF1B, with potential roles in mucosal barrier functions, colonic muscular development, and ribosomal RNA transcription, respectively. Copy number variants and lnc-EPB41-1-1 were also implicated. Genetic hotspots were identified on chromosomes 11, 17 and 16. RGPD2 and RGPD4, contributing to GTPase activator activity and known to be associated with bowel/colon, were differentially expressed. Pathway analysis highlighted Wnt and HOX pathways, with JAG1 and MLL relevant to CPC pathogenesis.
Conclusion
The study integrates genetic evidence and pathway analysis, shedding light on the complex genetic architecture of CPC. While the importance of genetic markers in the etiopathogenesis of CPC is underscored, the need for validating the findings on larger cohorts, diverse populations and through functional studies is suggested.